MWNA
ATRA icon

Marshall Wace North America’s Atara Biotherapeutics ATRA Stock Holding History

Marshall Wace North America’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-632
Closed -$227K – 1446
2021
Q1 		$227K Sell
632
-14,109
-96% -$6.24M ﹤0.01% 1383
2020
Q4 		$7.23M Buy
+14,741
New +$6.8M 0.03% 454
2020
Q3 		– Sell
-3,926
Closed -$1.43M – 1198
2020
Q2 		$1.43M Buy
+3,926
New +$992K 0.01% 666
2019
Q2 		– Sell
-1,973
Closed -$1.96M – 1147
2019
Q1 		$1.96M Buy
+1,973
New +$1.83M 0.01% 516
2018
Q1 		– Sell
-481
Closed -$218K – 1415
2017
Q4 		$218K Buy
+481
New +$178K ﹤0.01% 1275
2017
Q3 		– Sell
-1,214
Closed -$425K – 1247
2017
Q2 		$425K Buy
+1,214
New +$468K ﹤0.01% 1116

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return